Author

S de Groot

Observed names: Groot, S. de, S. Groot, S. de Groot

Institution: Leiden University Medical Center

Observed institutions: University of Southern California, Leiden University Medical Center, Erasmus MC, Medisch Centrum Leeuwarden, St. Antonius Ziekenhuis, Amphia Ziekenhuis, VieCuri Medisch Centrum, Ziekenhuis Gelderse Vallei, Bronovo Hospital, Haga Hospital, Borstkanker Onderzoek Groep, Deventer Ziekenhuis, Medisch Centrum Alkmaar

OpenAlex ID: A5110042480

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

2015 · S. de Groot, L. G. M. Janssen, et al. · Breast Cancer Research and Treatment · 30

Exploratory Analysis of Candidate Germline Gene Polymorphisms in Breast Cancer Patients Treated With Neoadjuvant Anthracycline-Containing Chemotherapy and Associations With Febrile Neutropenia

2015 · A Charehbili, S de Groot, et al. · Pharmacogenomics · 7

Hair follicle bulge cultures yield class III β-tubulin-positive melanoglial cells

2015 · H. Locher, N. Saadah, et al. · Histochemistry and Cell Biology · 6

Tumor-stroma ratio is associated with Miller-Payne and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer

2020 · S. Hagenaars, S. de Groot, et al. · European Journal of Cancer · 3

[Restless legs due to ingestion of 'light' beverages containing saccharine. Results of an N-of-1 trial].

2007 · S de Groot · PubMed · 3

Abstract P1-15-20: DIetary REstriction as an adjunct to neoadjuvant ChemoTherapy for HER2-negative breast cancer: Final results from the DIRECT trial (BOOG 2013-04)

2019 · S de Groot, RT Lugtenberg, et al. · Cancer Research · 2

Cn2 Real-world Cost-effectiveness of Oxaliplatin in Stage Iii Colon Cancer: a Synthesis of Trial Data With Data From Daily Clinical Practice

2010 · C van Gils, S de Groot, et al. · Value in Health · 2

Abstract OT3-1-03: DIRECT: A phase II/III randomized trial with dietary restriction as an adjunct to neoadjuvant chemotherapy for HER2-negative breast cancer

2013 · S de Groot, MPG Vreeswijk, et al. · Cancer Research · 1

Abstract P3-07-54: Insulin-like growth factor 1 receptor expression and polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial (BOOG 2010-01)

2016 · S de Groot, A Charehbili, et al. · Cancer Research

Abstract P3-06-50: Thyroid function is associated with the response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial on behalf of the Dutch Breast Cancer Research Group (BOOG 2010-01)

2015 · S de Groot, A Charehbili, et al. · Cancer Research

Works count: 13

Citation count: 54

H-index: 3

I10-index: 1